Jan-Hendrik B. Hardenberg, Andrea Braun, Michael P. Schön 

Slides:



Advertisements
Similar presentations
Chapter 14: Signaling Pathways That Control Gene Activity
Advertisements

Presented by Jeremy Smirnov. BCR and LFA-1 Induce B Cell Spreading Cell Spreading - a change in morphology that allows the B cell to “search” for antigens.
Date of download: 6/23/2016 From: Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates Ann Intern Med. 1993;119(12):
Control of Th2-Mediated Inflammation by Regulatory T Cells
Introduction to Receptors
Immune Receptors and Signal Transduction
Pharmacodynamics III Receptor Families
Copyright © 2015 by the American Osteopathic Association.
Thymocyte development summary
The Wnt signaling pathway in cancer
Figure 1. Functional classification of positive-acting transcription factors. Major functional groups are shown in black; specific examples are illustrated.
Cellular and Molecular Mechanisms of Liver Injury
Figure 2 Crosstalk between TGF-β/Smad and other pathways in tissue fibrosis Figure 2 | Crosstalk between TGF-β/Smad and other pathways in tissue fibrosis.
Molecular regulation of mast cell activation
Ian M. Adcock, PhD, Kittipong Maneechotesuwan, MD, Omar Usmani, MBBS 
TGFb –Superfamily Proteins
Cellular and Molecular Mechanisms of Liver Injury
Hedgehog signaling in the liver
Innate signals in mucosal immunoglobulin class switching
Primary Immunodeficiencies
Nat. Rev. Endocrinol. doi: /nrendo
Obstructive nephropathy: Insights from genetically engineered animals
Opsin3—A Link to Visible Light-Induced Skin Pigmentation
Nat. Rev. Rheumatol. doi: /nrrheum
Mechanisms of mast cell signaling in anaphylaxis
Daniel Abate-Daga, Marco L Davila  Molecular Therapy - Oncolytics 
T-cell activation through the antigen receptor
Volume 66, Issue 2, Pages (February 2017)
Volume 148, Issue 7, Pages (June 2015)
Figure 1 The major structure of kisspeptins in humans, the peptides encoded by theKISS1gene. All kisspeptins are the products generated by the cleavage.
Figure 1 The role of CTLA4 and PD1 in T cell activation
A New Twist in Smad Signaling
TGF-² Signaling Pathway in Lung Adenocarcinoma Invasion
Smads “Freeze” When They Ski
TIGIT-CD155 Interactions in Melanoma: A Novel Co-Inhibitory Pathway with Potential for Clinical Intervention  Karsten Mahnke, Alexander H. Enk  Journal.
Jo-Ellen Murphy, Caroline Robert, Thomas S. Kupper 
Volume 70, Issue 7, Pages (October 2006)
Targeting Smads to Restore Transforming Growth Factor-β Signaling and Regulatory T- Cell Function in Inflammatory Bowel Disease  Deanna D. Nguyen, Scott.
T Cells Are Smad’ly in Love with Galectin-9
The Molecular Basis of Lymphocyte Recruitment to the Skin: Clues for Pathogenesis and Selective Therapies of Inflammatory Disorders  Michael P. Schön,
The Bare Lymphocyte Syndrome: Molecular Clues to the Transcriptional Regulation of Major Histocompatibility Complex Class II Genes  Angela DeSandro, Uma.
Smad proteins and transforming growth factor-β signaling
Death receptor-mediated apoptosis and the liver
Molecular mechanisms of IgE regulation
The AhR–Nrf2 Pathway in Keratinocytes: On the Road to Chemoprevention?
Volume 19, Issue 5, Pages (September 2005)
Fibronectin at Select Sites Binds Multiple Growth Factors and Enhances their Activity: Expansion of the Collaborative ECM-GF Paradigm  Jia Zhu, Richard.
Chapter 16 Cell Communication.
Separating the Good and Evil of Cardiac Growth by CIB1 and Calcineurin
Volume 84, Issue 3, Pages (February 1996)
Alexander Kiani, Anjana Rao, Jose Aramburu  Immunity 
EMT and proteinuria as progression factors
RelA Life and Death Decisions
Eric N. Johnson, PhD, Kirk M. Druey, MD 
Vladimir A. Botchkarev  Journal of Investigative Dermatology 
Fig. 3 Conditionally expressed CAR using Notch as a signal induction and response pathway system. Conditionally expressed CAR using Notch as a signal induction.
Therapy of Alopecia Areata: On the Cusp and in the Future
Jeffrey C Rathmell, Craig B Thompson  Cell 
Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety  Philippe Bouchard, M.D., Nathalie Chabbert-Buffet,
Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases  Xiaoyu Hu, Lionel B. Ivashkiv  Immunity 
Force as a Facilitator of Integrin Conformational Changes during Leukocyte Arrest on Blood Vessels and Antigen-Presenting Cells  Ronen Alon, Michael L.
Volume 7, Issue 1, Pages 1-11 (July 1997)
Notch signaling from tumor cells: A new mechanism of angiogenesis
Yang Cang-Jin , Zhang Chi , Lu Yang-Ning , Jin Jia-Qi , Wang Xue-Lu  
CAR T cell immunotherapy for human cancer
Cell Signaling by Receptor Tyrosine Kinases
Elien Van Nuffel, Anja Schmitt, Inna S
The Regulatory T Cell Transcriptosome: E Pluribus Unum
Predicting Risk of Radiation-Induced Lung Injury
Update on glucocorticoid action and resistance
Presentation transcript:

A Yin and Yang in Epithelial Immunology: The Roles of the αE(CD103)β7 Integrin in T Cells  Jan-Hendrik B. Hardenberg, Andrea Braun, Michael P. Schön  Journal of Investigative Dermatology  Volume 138, Issue 1, Pages 23-31 (January 2018) DOI: 10.1016/j.jid.2017.05.026 Copyright © 2017 The Authors Terms and Conditions

Figure 1 Structure and putative functions of the αE(CD103)β7 integrin. (a) Domain structure of the αE(CD103)β7 integrin. The propeller, calf, and thigh domains of the αE(CD103) chain are shared with all known integrin α-subunits, whereas the α-I-domain is found in eight others. The X-domain containing a proteolytic cleavage site is unique to αE(CD103). Intracellular signaling is primarily dependent on the tail domain of the β7-chain, which also contains four EGF-like domains, two so-called hybrid domains separated by the β-I-domain, and a plexin/semaphorin/integrin domain. (b) Involvement of αE(CD103)β7 in selected intra- and extracellular signaling events. Binding of TGF-β to a type II receptor recruits and phosphorylates a type I receptor, which then recruits and phosphorylates Smad2 or Smad3. The latter dissociate from the receptor and oligomerize with Smad4. The oligomer translocates to the nucleus, recruits regulatory factors (DNA-binding factor, p300/CBP coactivator) and initiates target gene transcription. Concomitant TCR signaling and NFAT translocation to the nucleus is essential. On TCR stimulation, PLCγ1 is activated generating IP3, which induces calcium release, thus activating the NFAT pathway. The ITGAE gene (encoding for the αE(CD103) subunit) possesses enhancer elements binding NFAT and Smad3. Runx3-expressing cells increase expression of αE(CD103)β7 on exposure to TGF-β. The FoxP3 encoding gene also contains NFAT and Smad3 binding sites, thus providing a plausible explanation for the concomitant regulation of αE(CD103)β7 and FoxP3 by TGF-β. TGF-β receptor signaling can also activate ILK that in turn changes the conformation of αE(CD103)β7 and increases its affinity to E-cadherin. Chemokine receptor signaling can also increase the E-cadherin-directed affinity of αE(CD103)β7, and ligand binding by αE(CD103)β7 facilitates cytoskeleton rearrangement and promotes cell motility. The dashed lines indicate that underlying molecular mechanisms are largely unknown or hypothetical. (c) Putative role of the αE(CD103)β7 integrin at the immunological synapse. In the absence of LFA-1/ICAM-1, αE(CD103)β7 facilitates pSMAC formation after binding to its ligand, E-cadherin. The αE(CD103)β7/E-cadherin interaction can lead to clustering of CCR5 at the immunological synapse, which allows increased responses to CCL3 secreting target cells. Furthermore, the αE(CD103)β7/E-cadherin interaction causes recruitment of cytolytic granules to the cSMAC (central SMAC) via PLCγ signaling. Exocytosis is dependent on TCR engagement. CBP, CREB (cAMP-response element binding protein)-binding protein 1; CCL, chemokine (C-C motif) ligand; CCR, C-C-motif chemokine receptor; EGF, epidermal growth factor; FoxP3, forkhead box P3; ICAM-1, intracellular adhesion molecule 1; ILK, integrin-linked kinase; IP3, inositol triphosphate; LFA-1, lymphocyte function-associated antigen; NFAT, nuclear factor of activated T cells; PLC, phospholipase; Runx3, runt-related transcription factor 3; c/pSMAC, central/peripheral supramolecular activation cluster; TCR, T-cell receptor; TGF, transforming growth factor. Journal of Investigative Dermatology 2018 138, 23-31DOI: (10.1016/j.jid.2017.05.026) Copyright © 2017 The Authors Terms and Conditions